Van Tuyl Christopher — SEC insider filings
SEC reporting owner CIK 1779707. 11 insider filings on record with FilingPulse; latest filed 2026-10-09.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-12-18 to 2026-10-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 8 filings — 44,692 shares, $1,460,859 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 14,982 shares @ $38.19 ($572,163) in Immunovant, Inc., filed 2026-06-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Legal Officer | 11 | — | 11 legs · 44,692 sh · $1,460,859 | 8 |
Insider filings — Van Tuyl Christopher
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-09 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,327 @ $32.06 | EDGAR |
| 2026-09-25 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,846 @ $36.36 | EDGAR |
| 2026-07-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,143 @ $39.53 · Sale (S): 63 @ $39.99 | EDGAR |
| 2026-06-26 | 4 | Immunovant, Inc. (IMVT) | Option exercise (M): 17,824 @ $15.20 · Sale (S): 14,982 @ $38.19 · Sale (S): 2,842 @ $38.96 · Option exercise (M): 17,824 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,634 @ $35.39 | EDGAR |
| 2026-04-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 5,165 @ $24.83 | EDGAR |
| 2026-04-09 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 41,343 @ $0 · Grant/award (A): 59,820 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,877 @ $24.97 | EDGAR |
| 2025-12-19 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 8,529 @ $26.78 · Sale (S): 2,284 @ $27.38 | EDGAR |
| 2025-04-03 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 50,787 @ $0 · Grant/award (A): 71,531 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 109,956 @ $0 · Grant/award (A): 137,446 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1779707 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs